AI Summary & Key Takeaways
AI InsightNewly emerged symptoms during follow-up in patients with cancer should be taken into consideration, and be kept in mind that secondary tumors can be determined in one of every 20 patients in whom malignant tumuor was determined.
📌 3 Key Takeaways
Abstract
Renal cell carcinoma is the most frequently encountered malignancy of the kidney, and breast cancer is the the most frequent one in women. Synchronous occurrence of these two malignancies has rarely been reported. In this case, we presented a case of synchronous breast cancer and renal cell carcinoma. In patient with malignancy, it should be kept in mind that masses which are present or newly determined can be synchronic or metachronic malignancies besides metastasis. Newly emerged symptoms during follow-up in patients with cancer should be taken into consideration, and be kept in mind that secondary tumors can be determined in one of every 20 patients in whom malignant tumuor was determined.
Özet
Renal hücreli karsinom böbreğin en sık görülen malignite tipidir, meme kanseri ise kadınlarda en sık görülen malignite tipidir. Bu iki malignitenin senkron olarak birlikte görülmesi nadir olarak bildirilmiştir. Bu vakada, meme kanseri ve renal hücreli karsinom tanısı konan bir olgu bildirilmiştir. Malignite saptanan hastalarda mevcut olan veya sonradan ortaya çıkan kitlelerin, metastaz dışında senkron veya metakron maligniteler olabileceği akılda tutulmalıdır. Hastada takip sırasında yeni ortaya çıkan semptomlar dikkate alınmalıdır ve malign tümör saptanan her 20 hastadan birinde sekonder bir tümör gelişebileceği akılda tutulmalıdır.